Interpace Biosciences, Inc. (IDXG)
OTCMKTS · Delayed Price · Currency is USD
1.100
-0.040 (-3.51%)
Oct 29, 2025, 4:00 PM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202003 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2003 - 2019
Diagnostic Clinical Services
46.93M
Log In
Log In
Log In
Log In
Upgrade
Diagnostic Clinical Services Growth
16.69%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202003 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2003 - 2019
United States
46.93M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
16.69%
Log In
Log In
Log In
Log In
Upgrade